echemi logo
Product
  • Product
  • Supplier
  • Inquiry
    Home > Active Ingredient News > Infection > NEJM: The largest real-world study in history, subverting the perception of the side effects of the new crown vaccine

    NEJM: The largest real-world study in history, subverting the perception of the side effects of the new crown vaccine

    • Last Update: 2021-09-10
    • Source: Internet
    • Author: User
    Search more information of high quality chemicals, good prices and reliable suppliers, visit www.echemi.com

    More than a year has passed since the COVID-19 pandemic caused by the new coronavirus (SARS-CoV-2), and an unprecedented number of large-scale vaccination efforts are being carried out globally


    In the past, people used passive monitoring systems to collect information on vaccine safety, which relied on voluntary reports by individuals vaccinated, which would result in incomplete records


    On August 25, 2021, the Israeli Clalit Institute and the research team of Harvard University published a research paper titled: Safety of the BNT162b2 mRNA Covid-19 Vaccine in a Nationwide Setting in the New England Journal of Medicine (NEJM)


    The study used the comprehensive database of Israel's largest healthcare organization to evaluate the safety of the BNT162b2 mRNA vaccine and found that the vaccine was not associated with the increased risk of most adverse events


    After the new coronavirus infection, the risk of potentially serious adverse events such as myocarditis and many other serious adverse events is greatly increased, and the vaccine actually reduces these risks


    In order to provide the necessary background to explain the vaccine safety results, this study examined for the first time various adverse events between vaccinated individuals and unvaccinated individuals infected with the coronavirus


    The vaccination cohort included 1,736,832 people, with a median age of 43 years


    Compared with the unvaccinated group, the risk of adverse events in the vaccinated group was significantly higher than that in the unvaccinated group: myocarditis occurred 2.


    In order to provide the background of the above vaccine safety results, the research team conducted a separate analysis-the new crown infection cohort analysis


    The research team found that myocarditis is related to the vaccine, but it is rare, 2.


    Other adverse events associated with vaccination are lymphadenopathy (inflammation or swelling of the lymph nodes), which is a mild side effect that is part of the standard immune response to vaccination, and per 100,000 unvaccinated coronavirus infections There are 78 cases among people, and among vaccinated people, there are only 5 cases per 100,000 people


    Compared with the relatively small number of vaccine-related adverse reactions, unvaccinated people with coronavirus infection have a high incidence of serious adverse events, including: arrhythmia (3.


    In short, the largest real-world research data on the side effects of the new coronavirus vaccine shows that the BNT162b2 mRNA vaccine has nothing to do with the increased risk of most adverse events, and serious risks such as myocarditis are actually higher in unvaccinated people.


    Original source:

    Original source:

    Noam Barda, Noa Dagan, Yatir Ben-Shlomo, et al.


    Safety of the BNT162b2 mRNA Covid-19 Vaccine in a Nationwide Setting

    in this message
    This article is an English version of an article which is originally in the Chinese language on echemi.com and is provided for information purposes only. This website makes no representation or warranty of any kind, either expressed or implied, as to the accuracy, completeness ownership or reliability of the article or any translations thereof. If you have any concerns or complaints relating to the article, please send an email, providing a detailed description of the concern or complaint, to service@echemi.com. A staff member will contact you within 5 working days. Once verified, infringing content will be removed immediately.

    Contact Us

    The source of this page with content of products and services is from Internet, which doesn't represent ECHEMI's opinion. If you have any queries, please write to service@echemi.com. It will be replied within 5 days.

    Moreover, if you find any instances of plagiarism from the page, please send email to service@echemi.com with relevant evidence.